Effects of Empagliflozin on Erythropoiesis in Heart Failure: Data from the Empire HF Trial.

Camilla Fuchs AndersenMassar OmarAndreas GlenthøjDaniel El FassiHolger Jon MøllerJørgen Anders Lindholm KurtzhalsBjarne StyrishaveCaroline KistorpChristian TuxenMikael Kjaer PoulsenJens FaberLars KøberFinn GustafssonJacob Eifer MøllerMorten SchouJesper Jensen

Published in: European journal of heart failure (2022)

These findings suggest that empagliflozin increases erythropoiesis and augments early iron utilization in patients with HFrEF. These mechanisms may contribute to the cardioprotective properties of empagliflozin. This article is protected by copyright. All rights reserved.

Keyphrases

heart failure
acute heart failure
study protocol
clinical trial
electronic health record
left ventricular
atrial fibrillation
machine learning
deep learning
cardiac resynchronization therapy
data analysis